RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
C4 Therapeutics Stock

C4 Therapeutics Net Income 2024

C4 Therapeutics Net Income

-105.95 M USD

Ticker

CCCC

ISIN

US12529R1077

In 2024, C4 Therapeutics's profit amounted to -105.95 M USD, a -20.04% increase from the -132.49 M USD profit recorded in the previous year.

The C4 Therapeutics Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-

C4 Therapeutics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into C4 Therapeutics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by C4 Therapeutics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects C4 Therapeutics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of C4 Therapeutics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into C4 Therapeutics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing C4 Therapeutics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on C4 Therapeutics’s growth potential.

C4 Therapeutics Revenue, EBIT and net profit per share

DateC4 Therapeutics RevenueC4 Therapeutics EBITC4 Therapeutics Net Income
2029e5.71 B undefined0 undefined-81.72 M undefined
2028e3.33 B undefined869.47 M undefined-150.12 M undefined
2027e1.16 B undefined198.9 M undefined-203.77 M undefined
2026e17.69 M undefined-149.68 M undefined-110.88 M undefined
2025e21.29 M undefined-139.93 M undefined-118.08 M undefined
2024e29 M undefined-115.54 M undefined-105.95 M undefined
202320.76 M undefined-139.03 M undefined-132.49 M undefined
202231.1 M undefined-129.53 M undefined-128.18 M undefined
202145.79 M undefined-82.13 M undefined-83.89 M undefined
202033.2 M undefined-60.45 M undefined-66.34 M undefined
201921.38 M undefined-35.45 M undefined-42.57 M undefined
201819.36 M undefined-16.39 M undefined-24.11 M undefined

C4 Therapeutics stock margins

The C4 Therapeutics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of C4 Therapeutics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for C4 Therapeutics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the C4 Therapeutics's sales revenue. A higher gross margin percentage indicates that the C4 Therapeutics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the C4 Therapeutics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the C4 Therapeutics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the C4 Therapeutics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the C4 Therapeutics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the C4 Therapeutics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

C4 Therapeutics Margin History

C4 Therapeutics Gross marginC4 Therapeutics Profit marginC4 Therapeutics EBIT marginC4 Therapeutics Profit margin
2029e0 %0 %-1.43 %
2028e0 %26.13 %-4.51 %
2027e0 %17.18 %-17.6 %
2026e0 %-846.17 %-626.85 %
2025e0 %-657.25 %-554.64 %
2024e0 %-398.46 %-365.38 %
20230 %-669.84 %-638.34 %
20220 %-416.5 %-412.15 %
20210 %-179.36 %-183.21 %
20200 %-182.08 %-199.82 %
20190 %-165.81 %-199.11 %
20180 %-84.66 %-124.54 %

C4 Therapeutics Aktienanalyse

What does C4 Therapeutics do?

The company C4 Therapeutics Inc. was founded in 2015 and is headquartered in Watertown, Massachusetts. The company specializes in the development of drugs that work based on targeted protein degradation. This approach aims to specifically break down proteins in the body that are associated with various diseases. C4 Therapeutics develops special molecules that bind to these proteins and help break them down. The company's business model is based on collaboration with other companies in the pharmaceutical industry, where they develop drug candidates and license them to other companies for further development and marketing. C4 Therapeutics has a specialized strategy to become a leader in the field of targeted protein degradation. They are currently active in various areas, including the development of cancer drugs with a focus on proteins responsible for tumor growth, as well as neurology drugs for diseases like Alzheimer's and Parkinson's. Their important development is the PROTAC platform technology, which allows targeted protein degradation by binding two different molecules to the protein, triggering a cascade of reactions that lead to protein breakdown. Overall, C4 Therapeutics is an innovative and dynamic company specializing in drug development based on targeted protein degradation, with promising potential to treat a range of diseases. Despite being relatively young, the company has already achieved numerous successes and is expected to play an important role in the pharmaceutical industry in the future. C4 Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding C4 Therapeutics's Profit Margins

The profit margins of C4 Therapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of C4 Therapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating C4 Therapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

C4 Therapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When C4 Therapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about C4 Therapeutics stock

How much profit has C4 Therapeutics made this year?

C4 Therapeutics has made -105.95 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -20.04% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does C4 Therapeutics publish its earnings?

C4 Therapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of C4 Therapeutics?

The profits of C4 Therapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of C4 Therapeutics?

You can learn more about the earnings of C4 Therapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does C4 Therapeutics pay?

Over the past 12 months, C4 Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, C4 Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of C4 Therapeutics?

The current dividend yield of C4 Therapeutics is .

When does C4 Therapeutics pay dividends?

C4 Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of C4 Therapeutics?

C4 Therapeutics paid dividends every year for the past 0 years.

What is the dividend of C4 Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is C4 Therapeutics located?

C4 Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von C4 Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of C4 Therapeutics from 11/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did C4 Therapeutics pay the last dividend?

The last dividend was paid out on 11/6/2024.

What was the dividend of C4 Therapeutics in the year 2023?

In the year 2023, C4 Therapeutics distributed 0 USD as dividends.

In which currency does C4 Therapeutics pay out the dividend?

The dividends of C4 Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von C4 Therapeutics

Our stock analysis for C4 Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of C4 Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.